Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy

• Status: Completed
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the effectiveness and safety of DS-5565, compared to placebo, in subjects with pain associated with diabetic peripheral neuropathy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daiichi Sankyo Co., Ltd.
• Treatments: Pregabalin

Criteria

Inclusion Criteria:

• Type 1 or Type 2 diabetes mellitus

• Painful distal symmetric polyneuropathy

• Average daily pain score is great than or equal to 4

Exclusion Criteria:

• HbA1c greater than 9.0